FDA Grants Priority Review To Constipation Drug
Shares in Sucampo Pharmaceuticals Inc. rose by up to 10 percent after the company announced that US health regulators would be expediting their review of the company’s petition for wider use of its constipation drug Amitiza. Sucampo developed Amitiza in collaboration with Takeda Pharmaceutical Co Ltd. (Japan), and is seeking US approval for the use […]
1 min read